Cronos Group Inc. (CRON) Financial Statements
Industry: Medicinal Chemicals & Botanical Products
In fiscal 2025, Cronos reported revenue of $193.4M, up 19.5% from $161.8M the year before. Net income was -$9.4M (a -4.9% net margin), or -$0.02 per diluted share. Gross margin was 32.5% and operating margin was -9.0%. Operating activities generated $25.9M of cash, leaving $149,000 of free cash flow. At fiscal year end, Cronos held $1.20B in total assets against $54.2M in total liabilities, including $791.8M of cash and equivalents.
Open the full interactive Cronos financials → Quarterly statements, key ratios, valuation history and price charts.
Cronos Key Stats
| Share Price | $3.20 |
|---|---|
| Market Cap | $1.20B |
| Revenue YoY Growth | +19.5% |
| 52-Week Range | $2.30 – $3.55 |
| Shares Outstanding | 373.6 million (basic, 2026 Q2) |
Cronos Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $54.4M | $89.5M | $114.5M | $120.3M | $161.8M | $193.4M |
| Gross Profit | -$25.8M | -$17.5M | $12.0M | $11.9M | $25.2M | $62.8M |
| Operating Income | -$179.3M | -$560.6M | -$124.8M | -$84.8M | -$76.5M | -$17.4M |
| Pre-Tax Income | -$73.3M | -$397.1M | -$134.6M | -$73.7M | $36.6M | -$17.1M |
| Income Tax | $1.3M | -$431,000 | $34.2M | -$3.2M | -$3.4M | -$14.2M |
| Net Income | -$73.1M | -$396.1M | -$168.7M | -$74.0M | $41.1M | -$9.4M |
| Diluted EPS | -$0.21 | -$1.07 | -$0.45 | -$0.19 | $0.11 | -$0.02 |
Cronos Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $48.8M | $58.4M | $59.0M | $70.6M |
| Net Income | $26.0M | -$1.8M | $13.8M | $32.1M |
| Diluted EPS | $0.07 | -$0.00 | $0.04 | $0.09 |
Cronos Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.08B | $887.0M | $764.6M | $669.3M | $858.8M | $791.8M |
| Current Assets | $1.37B | $1.08B | $960.2M | $933.3M | $936.1M | $944.1M |
| Total Assets | $1.93B | $1.40B | $1.21B | $1.14B | $1.17B | $1.20B |
| Current Liabilities | $206.8M | $54.4M | $68.1M | $41.4M | $49.7M | $48.2M |
| Total Liabilities | $217.5M | $63.5M | $72.0M | $44.0M | $55.3M | $54.2M |
| Shareholders' Equity | $1.71B | $1.34B | $1.14B | $1.10B | $1.06B | $1.09B |
Cronos Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$142.5M | -$153.6M | -$88.9M | -$42.8M | $18.8M | $25.9M |
| Cash From Investing | $20.1M | -$28.9M | -$1.8M | -$59.5M | $175.1M | -$76.6M |
| Cash From Financing | -$5.5M | -$13.4M | -$2.9M | -$1.0M | -$1.2M | -$19.9M |
| Free Cash Flow | -$173.9M | -$164.8M | -$92.4M | -$45.3M | $6.4M | $149,000 |
Figures from Cronos' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Cronos financials page for every line item.
Cronos Company Profile
| Ticker | CRON |
|---|---|
| Exchange | Nasdaq |
| Industry | Medicinal Chemicals & Botanical Products |
| Headquarters | Stayner, Ontario, Canada |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer |
| SEC CIK | 0001656472 |
Frequently Asked Questions
What was Cronos' revenue in fiscal 2025?
Cronos (CRON) reported revenue of $193.4M for fiscal 2025.
What is Cronos' annual revenue history?
Cronos' annual revenue by fiscal year: 2020: $54.4M; 2021: $89.5M; 2022: $114.5M; 2023: $120.3M; 2024: $161.8M; 2025: $193.4M.
What was Cronos' net income in fiscal 2025?
Cronos reported net income of -$9.4M for fiscal 2025.
What was Cronos' earnings per share (EPS) in fiscal 2025?
Cronos' diluted EPS was -$0.02 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Cronos generate in fiscal 2025?
Cronos generated $149,000 of free cash flow in fiscal 2025.
What was Cronos' revenue last quarter?
In its most recent reported quarter (2026 Q2), Cronos reported revenue of $70.6M.
How many shares of Cronos are outstanding?
Cronos reported a weighted average of 373.6 million basic shares outstanding in 2026 Q2.
What is Cronos' market cap?
Based on its latest closing price, Cronos (CRON) has a market capitalization of about $1.20B.
When does Cronos' fiscal year end?
Cronos' fiscal year end, as registered with the SEC, is December 31.
Where is Cronos headquartered?
Cronos lists its business address in Stayner, Ontario, Canada in its SEC filings.
Cronos Competitors & Similar Companies
See all 11 Medicinal Chemicals & Botanical Products companies →